What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Enzyme
Naomi Kondo mostly deals with Genetics, Molecular biology, Immunology, Peroxisomal disorder and Peroxisome.
The study incorporates disciplines such as Point mutation, Gene mutation, Complementary DNA, Green fluorescent protein and Nuclear localization sequence in addition to Molecular biology.
The Immunology study combines topics in areas such as Peripheral blood mononuclear cell and Pneumonia.
Her research integrates issues of Zellweger syndrome and PEX6 in her study of Peroxisomal disorder.
Her biological study spans a wide range of topics, including Complementation and Exon.
Her research in Peroxisome intersects with topics in Complementation group, DNA ligase and Chinese hamster ovary cell.
Her most cited work include:
- Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity (546 citations)
- Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly (197 citations)
- Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. (143 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Immunology, Molecular biology, Genetics, Internal medicine and Gene.
As part of her studies on Immunology, Naomi Kondo frequently links adjacent subjects like Peripheral blood mononuclear cell.
Her Molecular biology research is multidisciplinary, relying on both Mutation, Mutant, Point mutation, Biochemistry and Complementary DNA.
Her studies in Exon, Allele, Zellweger syndrome, Peroxisomal disorder and Missense mutation are all subfields of Genetics research.
Her study looks at the relationship between Internal medicine and fields such as Endocrinology, as well as how they intersect with chemical problems.
Her Peroxisome research includes themes of Complementation, Biogenesis and Chinese hamster ovary cell.
She most often published in these fields:
- Immunology (28.67%)
- Molecular biology (23.86%)
- Genetics (20.24%)
What were the highlights of her more recent work (between 2008-2020)?
- Immunology (28.67%)
- Asthma (7.23%)
- Internal medicine (13.73%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Immunology, Asthma, Internal medicine, Genetics and Molecular biology.
Her study in Immunology is interdisciplinary in nature, drawing from both Casein, Complication, Mutation and Desensitization.
She has researched Asthma in several fields, including Immunoglobulin E, Pharmacokinetics and Intensive care medicine.
As a part of the same scientific study, she usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Compound heterozygosity and Mutation.
Her study in Thiolase and Haploinsufficiency is done as part of Genetics.
Her Molecular biology research incorporates themes from Gene, Mutant, Homologous recombination and Exon.
Between 2008 and 2020, her most popular works were:
- STXBP1 mutations in early infantile epileptic encephalopathy with suppression‐burst pattern (113 citations)
- Japanese Guideline for Food Allergy 2014. (84 citations)
- Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency (66 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Genetics, Molecular biology, Mutant, Mutation and Guideline are her primary areas of study.
Many of her studies involve connections with topics such as Agenesis of the corpus callosum and Genetics.
Within one scientific family, Naomi Kondo focuses on topics pertaining to RNA splicing under Molecular biology, and may sometimes address concerns connected to Mutation testing.
She interconnects IRAK4, Blot, HEK 293 cells, Reporter gene and Single-nucleotide polymorphism in the investigation of issues within Mutant.
Her Compound heterozygosity research focuses on Enzyme assay and how it connects with Internal medicine.
Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
